Our previous study identified a signal integration protein, Gab2, that is specifically and highly expressed in fatty liver, hepatitis, liver cancer, and other pathologies and integrates a variety of signaling pathways to promote the development of the disease [10,11]. This evidence concerns the gene GAB2 and liver cancer.